Pacira | Spese Operative



Operating Expenses Cambiamento Data
Astellas Pharma JPY 395.77B 237.82B 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
J&J USD 8.26B 10.37B 2025-03
Ligand Pharmaceuticals USD 52.45M 3.78M 2024-12
Novo Nordisk 37.49B 4.64B 2024-09
Pacira USD 162.55M 145.55M 2024-12
Perrigo USD 1.03B 13.4M 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
Teva Pharmaceutical Industries USD 3.77B 609M 2024-12
Xeris Pharmaceuticals USD 58.42M 8.74M 2024-12
Zoetis USD 1.59B 71M 2024-12



Pacira Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.